IRIS
PASTINA, PIERPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.345
EU - Europa 2.644
AS - Asia 1.272
SA - Sud America 239
Continente sconosciuto - Info sul continente non disponibili 108
AF - Africa 83
OC - Oceania 6
Totale 7.697
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.276
GB - Regno Unito 668
RU - Federazione Russa 589
IT - Italia 390
SG - Singapore 380
CN - Cina 371
IE - Irlanda 337
BR - Brasile 204
VN - Vietnam 188
UA - Ucraina 131
SE - Svezia 120
DE - Germania 111
HK - Hong Kong 98
FR - Francia 91
FI - Finlandia 82
BD - Bangladesh 55
IN - India 52
ZA - Sudafrica 49
ES - Italia 38
CA - Canada 36
TR - Turchia 34
KR - Corea 21
BE - Belgio 20
PL - Polonia 16
MX - Messico 14
NL - Olanda 13
AR - Argentina 10
AT - Austria 10
IQ - Iraq 10
NG - Nigeria 10
LT - Lituania 9
ID - Indonesia 8
IR - Iran 8
JP - Giappone 8
PK - Pakistan 8
VE - Venezuela 7
AU - Australia 6
UZ - Uzbekistan 6
CO - Colombia 5
KE - Kenya 5
TN - Tunisia 5
CI - Costa d'Avorio 4
GT - Guatemala 4
MA - Marocco 4
PY - Paraguay 4
SA - Arabia Saudita 4
AL - Albania 3
CL - Cile 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
JO - Giordania 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
DZ - Algeria 2
EG - Egitto 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
BW - Botswana 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
HT - Haiti 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 7.589
Salva come PNG Salva come JPEG
Città #
Southend 565
Dublin 326
Fairfield 288
Ashburn 285
Dallas 282
Singapore 246
San Jose 180
Moscow 178
Chandler 169
Santa Clara 155
Woodbridge 136
Ann Arbor 125
Wilmington 114
Houston 113
Seattle 111
Beijing 109
Jacksonville 105
Menlo Park 104
Milan 103
Council Bluffs 99
Hong Kong 93
New York 88
Cambridge 86
Siena 66
Ho Chi Minh City 60
Helsinki 47
Johannesburg 45
Los Angeles 45
Princeton 43
Fremont 41
Munich 41
Rome 38
Hefei 35
The Dalles 33
Hanoi 32
Dong Ket 30
Nanjing 28
Dearborn 27
Izmir 27
Buffalo 26
Shanghai 25
Florence 24
Lauterbourg 24
Málaga 23
Columbus 22
Seoul 21
Brussels 19
Boardman 17
San Diego 16
London 14
San Mateo 14
Turku 13
Warsaw 13
Falkenstein 12
Frankfurt am Main 12
Montreal 12
Shenyang 12
Toronto 11
Abuja 10
Atlanta 10
Da Nang 9
Denver 9
Hebei 9
Orem 9
Phoenix 9
Tianjin 9
Manchester 8
Nuremberg 8
Poplar 8
Redondo Beach 8
Stockholm 8
Tokyo 8
Vienna 8
Brooklyn 7
Dhaka 7
Figino 7
Guangzhou 7
Haiphong 7
Jinan 7
Lancaster 7
Mumbai 7
Nanchang 7
Ningbo 7
São Paulo 7
Barnet 6
Belo Horizonte 6
Chennai 6
Fort Worth 6
Jiaxing 6
Lappeenranta 6
Miami 6
Rio de Janeiro 6
San Francisco 6
Zanjan 6
Bologna 5
Boston 5
Brasília 5
Changsha 5
Chicago 5
Espoo 5
Totale 5.325
Salva come PNG Salva come JPEG
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 413
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures 379
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients 349
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 334
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS) 326
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 307
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy 296
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 296
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT 286
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 278
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 277
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide. 267
Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide 245
Inflammatory status and lymphocyte of infiltration of primary tumor predict survival of prostate cancer patients undergone prostate radical radiotherapy 219
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 218
Immune-modulating effects of the newest cetuximab-based chemoimmunotherapy regimen in advanced colorectal cancer patients 216
The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer 213
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 179
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures. 177
CDK4, CDK6/cyclin‐d1 complex inhibition and radiotherapy for cancer control: a role for autophagy 170
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma 158
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma. 148
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab 147
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation. 147
In Regard to Kubicek et al. 146
null 139
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 130
null 130
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 128
null 126
Immunotherapy of colorectal cancer: new perspectives after a long path. 122
null 117
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? 111
Magnetic-resonance-imaging texture analysis predicts early progression in rectal cancer patients undergoing neoadjuvant chemoradiation 105
null 92
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review 90
null 82
Role of the Appropriateness of the Pelvic Lymphadenectomy and Adjuvant Radiation Therapy in Early-Stage Poorly Differentiated Endometrial Carcinoma 70
Timing matters: overall treatment time, radiotherapy interruptions, and outcomes in glioblastomas—prognostic significance in different biological sub-groups 64
Totale 7.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022325 0 0 38 18 25 18 20 29 29 38 39 71
2022/2023533 26 60 77 80 50 86 11 40 51 31 9 12
2023/2024539 9 6 63 23 15 150 240 0 2 12 2 17
2024/2025867 27 36 110 52 109 58 17 65 41 31 114 207
2025/20262.770 182 272 250 345 682 121 294 72 77 173 90 212
2026/2027265 127 82 56 0 0 0 0 0 0 0 0 0
Totale 7.697